Valentina Ientile
About
Valentina Ientile is a scholar working on Immunology, Economics and Econometrics and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Valentina Ientile has authored 28 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Economics and Econometrics and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Valentina Ientile's work include Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical Economics and Policy (5 papers). Valentina Ientile is often cited by papers focused on Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Pharmaceutical Economics and Policy (5 papers). Valentina Ientile collaborates with scholars based in Italy, Netherlands and United Kingdom. Valentina Ientile's co-authors include Gianluca Trifirò, Ylenia Ingrasciotta, Andrea Fontana, Achille P. Caputi, Carmen Ferrajolo, Valentina Isgrò, Paola Maria Cutroneo, Michele Tari, Laura Sottosanti and Francesco Giorgianni and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Environmental Research and Public Health.
In The Last Decade
Valentina Ientile
27 papers receiving 275 citations
Peers
Valentina Ientile
Giuseppe Traversa Italy
Mo Dimbil United States
Hoi Y. Tong Spain
Sruthi Adimadhyam United States
Rosa Romero‐Jiménez Spain
Alberto Costantini Italy
Yinghong Zhai China
Aurélie Grandvuillemin France
Marie‐Blanche Valnet‐Rabier France
Amy J. Hatfield United States
Citations per year, relative to Valentina Ientile Valentina Ientile (= 1×)
peers
Giuseppe Traversa
Countries citing papers authored by Valentina Ientile
Since
Specialization
Citations
This map shows the geographic impact of Valentina Ientile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Ientile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Ientile more than expected).
Fields of papers citing papers by Valentina Ientile
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Valentina Ientile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Ientile. The network helps show where Valentina Ientile may publish in the future.
Co-authorship network of co-authors of Valentina Ientile
This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Ientile. A scholar is included among the top collaborators of Valentina Ientile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Ientile. Valentina Ientile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
L’Abbate, Luca, Ylenia Ingrasciotta, Valentina Ientile, et al.. (2024). Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project. Clinical Epidemiology. Volume 16. 395–407.
2.
Ingrasciotta, Ylenia, Valentina Isgrò, Valentina Ientile, et al.. (2023). Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy. Clinical Epidemiology. Volume 15. 309–321.
3.
Roberto, Giuseppe, Francesco Barone‐Adesi, Valentina Ientile, et al.. (2022). Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study. Frontiers in Pharmacology. 13. 871052–871052.
4.
Crisafulli, Salvatore, Andrea Fontana, Luca L’Abbate, et al.. (2022). Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases. Scientific Reports. 12(1). 15843–15843.
5.
Ingrasciotta, Ylenia, Andrea Fontana, Valentina Ientile, et al.. (2021). Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy. Pharmaceuticals. 14(4). 290–290.
6.
Ingrasciotta, Ylenia, Valentina Isgrò, Valentina Ientile, et al.. (2021). Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy. Journal of Clinical Medicine. 10(15). 3431–3431.
7.
Kuiper, Josephina G., Ylenia Ingrasciotta, Valentina Ientile, et al.. (2021). Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries. Frontiers in Oncology. 11. 630456–630456.
8.
Ingrasciotta, Ylenia, Janet Sultana, Valentina Ientile, et al.. (2020). Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?. Pharmacoepidemiology and Drug Safety. 30(1). 65–77.
9.
Isgrò, Valentina, Janet Sultana, Andrea Fontana, et al.. (2020). Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions. ERJ Open Research. 6(3). 279–2020.
10.
Sultana, Janet, Gianluca Trifirò, Valentina Ientile, et al.. (2020). Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis. Frontiers in Pharmacology. 11. 1232–1232.
11.
Ientile, Valentina, et al.. (2020). Real-world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study of years 2010-2014 from Southern Italy. Giornale Italiano di Dermatologia e Venereologia. 155(4). 441–451.
12.
Sultana, Janet, Francesco Giorgianni, Valentina Ientile, et al.. (2020). Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study. Drug Safety. 43(9). 943–952.
13.
Belleudi, Valeria, Francesco Trotta, Antonio Addis, et al.. (2019). Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study. Drug Safety. 42(12). 1437–1447.
14.
Ingrasciotta, Ylenia, Valeria Belleudi, Francesco Trotta, et al.. (2019). In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study. BioDrugs. 34(1). 55–64.
15.
Ferrajolo, Carmen, Janet Sultana, Valentina Ientile, et al.. (2019). Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy. Frontiers in Pharmacology. 10. 11–11.
16.
Ingrasciotta, Ylenia, Francesco Giorgianni, Valentina Ientile, et al.. (2018). Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009–2014. Frontiers in Endocrinology. 9. 95–95.
17.
Cutroneo, Paola Maria, Valentina Ientile, Laura Sottosanti, et al.. (2017). Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System. Drug Safety. 40(11). 1131–1140.
18.
Ingrasciotta, Ylenia, Francesco Giorgianni, Alessandro Chinellato, et al.. (2016). Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study. PLoS ONE. 11(5). e0155805–e0155805.
19.
Sultana, Janet, Umberto M. Musazzi, Ylenia Ingrasciotta, et al.. (2015). Medication is an additional source of phosphate intake in chronic kidney disease patients. Nutrition Metabolism and Cardiovascular Diseases. 25(10). 959–967.
20.
Cutroneo, Paola Maria, Valentina Isgrò, Alessandra Russo, et al.. (2014). Safety Profile of Biological Medicines as Compared with Non-Biologicals: An Analysis of the Italian Spontaneous Reporting System Database. Drug Safety. 37(11). 961–970.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Giuseppe Traversa Breakdown of academic impact, for papers by Mo Dimbil Breakdown of academic impact, for papers by Hoi Y. Tong Breakdown of academic impact, for papers by Sruthi Adimadhyam Breakdown of academic impact, for papers by Rosa Romero‐Jiménez Breakdown of academic impact, for papers by Alberto Costantini Breakdown of academic impact, for papers by Yinghong Zhai Breakdown of academic impact, for papers by Aurélie Grandvuillemin Breakdown of academic impact, for papers by Marie‐Blanche Valnet‐Rabier Breakdown of academic impact, for papers by Amy J. Hatfield